| Journal | Spine |
| Study Type | Systematic Review |
| Population | Human participants |
This meta-analysis addresses a critical perioperative question as cannabis use becomes more prevalent among surgical patients. Understanding how preoperative cannabis affects spinal fusion outcomes helps clinicians counsel patients and optimize perioperative care protocols.
This systematic review analyzed 7 retrospective studies including 1,920 patients (386 cannabis users) undergoing spinal fusion procedures. Cannabis users required significantly more in-hospital opioids (58.84 additional morphine milligram equivalents), had higher readmission rates (70% increased odds), and nearly 4-fold higher reoperation rates compared to non-users. The findings suggest preoperative cannabis use may complicate postoperative recovery, though the retrospective design limits causal inference and patient selection factors weren’t fully controlled.
“These results align with what I observe clinically – patients with regular cannabis use often have altered pain perception and opioid tolerance that complicates postoperative management. However, I’m cautious about drawing definitive conclusions from retrospective data that can’t account for underlying pain severity or other confounding factors that drive both cannabis use and poor surgical outcomes.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
Table of Contents
- FAQ
- Does preoperative cannabis use affect opioid requirements after spinal fusion surgery?
- Are cannabis users at higher risk for complications after spinal fusion surgery?
- Should I stop using cannabis before my scheduled spinal fusion surgery?
- How reliable is this evidence about cannabis and spinal fusion outcomes?
- What should spine surgeons know about patients who use cannabis preoperatively?
FAQ
Does preoperative cannabis use affect opioid requirements after spinal fusion surgery?
Yes, patients with preoperative cannabis use require significantly more in-hospital opioids after spinal fusion procedures. This meta-analysis found an increase of approximately 59 morphine milligram equivalents (MME) compared to non-cannabis users, likely due to cross-tolerance effects between cannabis and opioids.
Are cannabis users at higher risk for complications after spinal fusion surgery?
Cannabis users face significantly higher rates of both readmission (70% increased odds) and reoperation (nearly 4-fold increased odds) following spinal fusion procedures. These findings suggest preoperative cannabis use is associated with worse perioperative outcomes and surgical complications.
Should I stop using cannabis before my scheduled spinal fusion surgery?
While this study doesn’t specify cessation timing, the evidence shows preoperative cannabis use leads to increased opioid requirements and complications. Patients should discuss cannabis cessation with their surgical team well before the procedure to optimize perioperative outcomes and pain management strategies.
How reliable is this evidence about cannabis and spinal fusion outcomes?
This systematic review analyzed 7 retrospective studies involving 1,920 patients, with 386 cannabis users, providing substantial evidence. However, all included studies were retrospective, and more prospective research is needed to establish definitive causation and optimal perioperative management protocols.
What should spine surgeons know about patients who use cannabis preoperatively?
Surgeons should anticipate higher opioid requirements and prepare enhanced pain management protocols for cannabis-using patients. Additionally, these patients may need closer postoperative monitoring and follow-up given the significantly increased risks of readmission and reoperation identified in this analysis.